Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) to participate in the 42nd Annual J.P. Morgan Healthcare Conference. Joaquin Duato, Chairman and CEO, to represent the company in a session on January 8th, 12:45 p.m. (Eastern Time). Audio webcast available on www.investor.jnj.com.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the 42^nd Annual J.P. Morgan Healthcare Conference on Monday, January 8^th, at the Westin St. Francis in San Francisco, CA. Joaquin Duato, Chairman and Chief Executive Officer will represent the Company in a session scheduled at 12:45 p.m. (Eastern Time)

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231207061298/en/

Media:

media-relations@its.jnj.com



Investor:

investor-relations@its.jnj.com

Source: Johnson & Johnson

FAQ

When will Johnson & Johnson participate in the 42nd Annual J.P. Morgan Healthcare Conference?

Johnson & Johnson will participate on Monday, January 8th.

Who will represent Johnson & Johnson at the conference?

Joaquin Duato, Chairman and CEO, will represent the company.

Where can investors access the live audio webcast?

Investors can access the webcast on www.investor.jnj.com.

When will the audio webcast replay be available?

The replay will be available approximately 48 hours after the webcast.